ProQR Therapeutics N.V. - PRQR

SEC FilingsOur PRQR Tweets

About Gravity Analytica

Recent News

  • 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
  • 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
  • 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
  • 05.08.2025 - ProQR Announces First Quarter 2025 Operating and Financial Results
  • 05.08.2025 - ProQR Announces First Quarter 2025 Operating and Financial Results
  • 05.02.2025 - ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
  • 05.01.2025 - ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
  • 04.14.2025 - ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
  • 03.13.2025 - ProQR Announces Year End 2024 Operating and Financial Results
  • 03.13.2025 - ProQR Announces Year End 2024 Operating and Financial Results

Recent Filings

  • 05.08.2025 - EX-99.1 EX-99.1
  • 05.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 05.01.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 05.01.2025 - EX-99.1 EX-99.1
  • 04.14.2025 - EX-99.1 EX-99.1
  • 04.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 03.25.2025 - EFFECT Notice of Effectiveness
  • 03.25.2025 - 424B5 Prospectus [Rule 424(b)(5)]
  • 03.21.2025 - CORRESP Correspondence
  • 03.20.2025 - UPLOAD SEC-generated letter